Clinical Trials in Massachusetts

Showing 8621-8640 of 13,570 trials

Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents

NCT02402933

Up to fifty (50) children and adolescents with type 1 diabetes (T1D) aged 4 to ˂18 years at time of enrolment will be selected for inclusion in the study. The target is to obtain treatment response and user-experience data following use of Nasal Glucagon (LY900018) in treating episodes of hypoglycemia.

HypoglycemiaDiabetes Mellitus

Eli Lilly and Company26 participantsStarted Mar 2015

Tallahassee, Florida, United States • Baltimore, Maryland, United States • Waltham, Massachusetts, United States

COMPLETEDPhase 226 miles

A Study in Participants With Moderate to Severe Psoriasis

NCT01107457

The primary purpose for this study is to help answer the following research questions * The safety of ixekizumab (LY2439821) and any side effects that might be associated with it. * Whether ixekizumab can help participants with Psoriasis. * How much ixekizumab should be given to participants.

Psoriasis

Eli Lilly and Company142 participantsStarted Apr 2010

Bakersfield, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +31 more locations

Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents

A Study in Participants With Moderate to Severe Psoriasis

Find Trials by Condition in Massachusetts

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

Gene Expression During Surgical Scar Remodeling by Fractional Photothermolysis

Evaluation of Mallampati Score Changes in Pregnancy

A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

A Study in Non-Small Cell Lung Cancer

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma

1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

A Study of LY3015014 in Participants With High Cholesterol

Long-Term Assessment of Remyelinating Therapy

A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications

A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus

Maximizing CRT Delivery by Using MultipolAr Coronary Sinus Lead FamiLy ACUITY® X4 - RALLY X4 Study

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes